SCHEMBL27344460

SCHEMBL27344460

FC1(F)CCN(c2cncc(Br)n2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 2/20 0.39
▸ PIM3 Q86V86 2/20 0.39
▸ PIM2 Q9P1W9 2/20 0.39
▸ CNR2 P34972 4/20 0.36
▸ CYP11B1 P15538 4/20 0.36
▸ CYP11B2 P19099 4/20 0.36
▸ MAP3K12 Q12852 2/20 0.33
▸ DPP4 P27487 2/20 0.33
▸ MAP3K13 O43283 1/20 0.33
▸ KLKB1 P03952 2/20 0.33
▸ KLK1 P06870 2/20 0.33
▸ PDE10A Q9Y233 2/20 0.33
▸ GBA1 P04062 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12813743 0.81 KDM4E (0.53) PIM1PIM3PIM2CNR2CYP11B1
SCHEMBL15854633 0.73 CYP11B1 (0.39) PIM1PIM3PIM2CNR2CYP11B1
SCHEMBL30643023 0.73 KDM4E (0.60) PIM1PIM3PIM2CNR2CYP11B1
SCHEMBL12615343 0.73 KDM4E (0.60) PIM1PIM3PIM2CNR2CYP11B1
SCHEMBL22152111 0.73 PIM1 (0.41) PIM1PIM3PIM2CNR2CYP11B1
SCHEMBL25027553 0.73 HTR2A (0.42) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL418886 0.73 HTR2A (0.42) PIM2CYP11B1CYP11B2PDE10AKDM4E
SCHEMBL31014861 0.73 PIM1 (0.39) PIM1PIM3PIM2CNR2CYP11B1
SCHEMBL30811648 0.71 CHRNB2 (0.54) CYP11B1CYP11B2
SCHEMBL17316736 0.71 GRIN2D (0.47) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217989-A1 Heteroaryl Fluoroalkenes As DGK Inhibitors INCYTE CORPORATION 2024-07-04 — — US disclosed
US-20240217989-A1 Heteroaryl Fluoroalkenes As DGK Inhibitors INCYTE CORPORATION 2024-07-04 — — US disclosed
US-20240217989-A1 Heteroaryl Fluoroalkenes As DGK Inhibitors INCYTE CORPORATION 2024-07-04 — — US disclosed
WO-2024108100-A1 HETEROARYL FLUOROALKENES AS DGK INHIBITORS INCYTE CORPORATION (US) 2024-05-23 — — WO disclosed
WO-2024108100-A1 HETEROARYL FLUOROALKENES AS DGK INHIBITORS INCYTE CORPORATION (US) 2024-05-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217989-A1 Heteroaryl Fluoroalkenes As DGK Inhibitors DGKA, DGKG, DGKK PIM1 1245/4885PIM3 1126/4885PIM2 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback